Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.42 USD | +3.92% | +7.17% | -16.63% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 68.47M | Sales 2025 * | 59.1M | Capitalization | 2.45B |
---|---|---|---|---|---|
Net income 2024 * | -490M | Net income 2025 * | -515M | EV / Sales 2024 * | 27.5 x |
Net cash position 2024 * | 567M | Net cash position 2025 * | 509M | EV / Sales 2025 * | 32.9 x |
P/E ratio 2024 * |
-4.93
x | P/E ratio 2025 * |
-4.95
x | Employees | 526 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.8% |
Latest transcript on Intellia Therapeutics, Inc.
1 day | +3.92% | ||
1 week | +7.17% | ||
Current month | +18.79% | ||
1 month | +4.74% | ||
3 months | -3.89% | ||
6 months | +6.76% | ||
Current year | -16.63% |
Managers | Title | Age | Since |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Glenn Goddard
DFI | Director of Finance/CFO | 53 | 18-10-28 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 19-01-23 |
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Frank Verwiel
CHM | Chairman | 62 | 17-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.15% | 2 M€ | -25.75% | ||
4.87% | 1 M€ | 0.00% | - | |
4.17% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 25.42 | +3.92% | 1,697,948 |
24-05-10 | 24.46 | -1.61% | 2,042,656 |
24-05-09 | 24.86 | +8.09% | 1,669,933 |
24-05-08 | 23 | -3.69% | 1,375,019 |
24-05-07 | 23.88 | +0.67% | 1,096,319 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.63% | 2.45B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- NTLA Stock